Ignite Creation Date:
2025-12-24 @ 4:35 PM
Ignite Modification Date:
2025-12-28 @ 4:51 PM
Study NCT ID:
NCT05208866
Status:
TERMINATED
Last Update Posted:
2023-05-12
First Post:
2022-01-07
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Roll-over Study to Assess Safety of Lixivaptan in Participants With ADPKD Who Completed Study PA-ADPKD-303
Sponsor:
Palladio Biosciences
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-02-10
Start Date Type:
ACTUAL
Primary Completion Date:
2022-06-29
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-07-29
Completion Date Type:
ACTUAL
First Submit Date:
2022-01-07
First Submit QC Date:
None
Study First Post Date:
2022-01-26
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-02-08
Results First Submit QC Date:
None
Results First Post Date:
2023-04-10
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-04-17
Last Update Post Date:
2023-05-12
Last Update Post Date Type:
ACTUAL